Year archive

Cutia Therapeutics — 2025 filings

All 40 regulatory filings released by Cutia Therapeutics (2487) in 2025, sourced directly from the official regulator.

40 Filings

2025 Period

2025 filings (40)

Filing	Released	Lang
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-12-30	English
CHANGE OF NON-EXECUTIVE DIRECTOR Board/Management Information	2025-12-30	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Regulatory Filings	2025-12-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 Share Issue/Capital Change	2025-12-04	English
VOLUNTARY ANNOUNCEMENT - ABBREVIATED NEW DRUG APPLICATION FOR CU-40105 (SELF-DEVELOPED TOPICAL FINASTERIDE SPRAY) ACCEPTED BY THE NMPA Regulatory Filings	2025-11-18	English
VOLUNTARY ANNOUNCEMENT - POST-HOC ANALYSIS OF PHASE III CLINICAL TRIAL OF CU-10201 (TOPICAL 4% MINOCYCLINE FOAM) IN THE PRC ACCEPTED FOR ORAL PRESENTATION AT THE 20TH CDA ANNUAL MEETING Regulatory Filings	2025-11-10	English
Next Day Disclosure Return Share Issue/Capital Change	2025-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 Regulatory Filings	2025-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 Regulatory Filings	2025-10-03	English
2025 Interim Report Interim / Quarterly Report H1 2025	2025-09-26	English
Next Day Disclosure Return Share Issue/Capital Change	2025-09-05	English
COMPLETION OF PLACING OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-09-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 Regulatory Filings	2025-09-04	English
PLACING OF NEW SHARES UNDER GENERAL MANDATE Share Issue/Capital Change	2025-08-29	English
(1) CHANGE OF COMPANY SECRETARY, AUTHORISED REPRESENTATIVE, PROCESS AGENT; AND (2) CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG Board/Management Information	2025-08-28	English
TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE OF CUTIA THERAPEUTICS Governance Information	2025-08-28	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2025-08-28	English
(1) CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (2) CHANGE OF MEMBERS OF NOMINATION COMMITTEE AND AUDIT COMMITTEE Board/Management Information	2025-08-28	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 Interim / Quarterly Report H2 2025	2025-08-28	English
DATE OF BOARD MEETING Report Publication Announcement	2025-08-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 Share Issue/Capital Change	2025-08-05	English
VOLUNTARY ANNOUNCEMENT - CU-40102 (TOPICAL FINASTERIDE SPRAY) OBTAINED MARKETING APPROVAL BY THE HONG KONG DEPARTMENT OF HEALTH Regulatory Filings	2025-08-01	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 Regulatory Filings	2025-07-04	English
VOLUNTARY ANNOUNCEMENT - CU-40102 (TOPICAL FINASTERIDE SPRAY) OBTAINED MARKETING APPROVAL BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2025-06-30	English
VOLUNTARY ANNOUNCEMENT - RESULTS OF PHASE III CLINICAL TRIAL OF CU-30101 (LOCALIZED TOPICAL LIDOCAINE AND TETRACAINE CREAM) IN CHINA ACCEPTED FOR E-POSTER PRESENTATION AT THE 30TH ANNUAL MEETING OF CS Regulatory Filings	2025-06-27	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2025 Regulatory Filings	2025-06-05	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 5 JUNE 2025 Declaration of Voting Results & Voting Rights Announcements	2025-06-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2025 Regulatory Filings	2025-05-08	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 5 JUNE 2025 Proxy Solicitation & Information Statement	2025-04-22	English
NOTICE OF ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2025-04-22	English
(1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES (3) PROPOSED RE-APPOINTMENT OF AUDITOR AND (4) NOTICE OF ANNUAL GENERA Proxy Solicitation & Information Statement	2025-04-22	English
2024 Environmental, Social and Governance Report Environmental & Social Information	2025-04-22	English
2024 Annual Report Annual Report FY 2024	2025-04-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2025 Regulatory Filings	2025-04-03	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2024 Earnings Release FY 2024	2025-03-24	English
DATE OF BOARD MEETING Report Publication Announcement	2025-03-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025 Regulatory Filings	2025-03-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2025 Regulatory Filings	2025-02-05	English
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG Regulatory Filings	2025-01-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2024 Regulatory Filings	2025-01-03	English